Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$139.28B | 36.2x | 1.8 | A$287.65 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.3% Upside | Upgrade to Pro+ | |
Resmed DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | A$51.38B | 35x | 2.59 | A$35.04 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.7% Downside | Upgrade to Pro+ | |
Fisher&Paykel Healthcare | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.20B | 156.7x | -3.41 | A$32.76 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.3% Upside | Upgrade to Pro+ | |
Cochlear | Sydney | Healthcare | Healthcare Equipment & Supplies | A$18.44B | 51.8x | 2.72 | A$281.61 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.8% Upside | Upgrade to Pro+ | |
Pro Medicus Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$18.32B | 220.9x | 5.97 | A$175.31 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -19% Downside | Upgrade to Pro+ | |
Sonic Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$12.83B | 25x | -0.95 | A$26.71 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.2% Downside | Upgrade to Pro+ | |
Ramsay Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$9.42B | 10.8x | 0.18 | A$41.21 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Ramsay Health Care Pref | Sydney | Healthcare | Healthcare Providers & Services | A$9.42B | 10.8x | A$103.85 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$6.85B | 134.9x | 0.7 | A$20.42 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.8% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.48B | 23.6x | 3.87 | A$33.32 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
Ansell | Sydney | Healthcare | Healthcare Equipment & Supplies | A$4.58B | 36.6x | -0.83 | A$31.65 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$2.75B | -44.3x | 1.02 | A$8.59 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.5% Downside | Upgrade to Pro+ | |
Summerset Group | Sydney | Healthcare | Healthcare Providers & Services | A$2.36B | 6.3x | 0.13 | A$10.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$2.23B | 351.3x | 4.12 | A$1.42 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.1% Downside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$1.92B | 16.4x | 0.14 | A$15.06 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Regis Healthcare Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$1.86B | -86.9x | -3.36 | A$6.18 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.3% Upside | Upgrade to Pro+ | |
Polynovo | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.81B | 326.3x | 1.58 | A$2.62 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.5% Upside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$1.26B | -8.5x | -0.6 | A$1.10 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | |
Primary Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$1.25B | -1.8x | 0.04 | A$1.72 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.6% Downside | Upgrade to Pro+ | |
Nanosonics | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.14B | 87x | -2.38 | A$3.73 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.8% Downside | Upgrade to Pro+ | |
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | A$960.25M | -1.5x | 0.38 | A$0.78 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.8% Upside | Upgrade to Pro+ | |
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$839.90M | -18x | 0.49 | A$0.18 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Australian Clinical Labs | Sydney | Healthcare | Healthcare Providers & Services | A$728.87M | 28.2x | -0.91 | A$3.57 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -8% Downside | Upgrade to Pro+ | |
Paragon Care Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$720.06M | 48.1x | -0.86 | A$0.43 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.7% Upside | Upgrade to Pro+ | |
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$710.77M | 19.9x | 1.12 | A$14.22 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Integral Diagnostics Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$699.41M | -11.5x | 0.03 | A$2.99 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | |
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$689.33M | -42.2x | 2.98 | A$0.38 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oceania Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$503.34M | 17.2x | 0.18 | A$0.69 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$479.36M | -9.3x | -0.57 | A$0.33 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Monash IVF Group Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$471.46M | -71.3x | 0.54 | A$1.21 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24% Upside | Upgrade to Pro+ |